money to help them develop depth. So it's it's from that standpoint it's a good relationship. The FDA. What GileadSciences might make a lot of money on this the FDA has just approved a new. Drug to treat HIV it's a daily drug. In the

General Electric who knew I didn't think they had any money left to develop it. Amgen was on the list Qualcomm GileadSciences Coca-Cola Intel Omer Amazon Pfizer. Pepsi Procter & Gamble and Johnson Johnson all with bill literally folks billions

And now the financial exchange we've Barry Armstrong and shocks. Secure. For cancer is getting closer and closer GileadSciences . Eleven billion dollar bet. On buying kite pharmaceutical incorporated is poised to pay off. With the approval

education listeners don't know what's driving it was yesterday's big news were Gilead Sciences by his. Kite pharmaceuticals. Now the reason that's big deals because kite or rather Gilead finally put their warts they're 35 billion dollar war chest to work and bought somebody to develop. And kite is in this.